SLSN — Solesence, Inc. Common Stock
NASDAQ · Consumer Defensive · Household & Personal Products
$0.91
+$0.00 (+0.54%)
Solesence, Inc. Common Stock (SLSN) is a household & personal products company listed on NASDAQ. It is led by Jess A. Jankowski, based in 1319 Marquette Drive, Romeoville, IL, United States, 60446, with about 98 employees. Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin health products, such as sunscreens and daily care products; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, and medical diagnostics applications. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
Latest reported SLSN revenue for 2026-06-30 was $15.3M. Net income was -$158.0K. Revenue was up 18.3% from 2026-03-31 to 2026-06-30.
Use this SLSN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SLSN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SLSN SEC filings page. Lician reads the product cache first so this HTML stays unique to Solesence, Inc. Common Stock even when a live quote feed is slow.
About Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin health products, such as sunscreens and daily care products; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, and medical diagnostics applications. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
SLSN Key Statistics
Market Cap
$0.00M
Volume
6,422
Previous Close
$0.94
Day Range
$0.92 – $0.97
EPS
$0.02
Revenue
$62.06M
Net Income
$1.79M
Gross Profit
$16.06M
Free Cash Flow
$0.00
Revenue Growth
+18.6%
Profit Margin
2.9%
Debt to Equity
0.00
Employees
98
SLSN Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $62.06M | $52.35M |
| Cost of Revenue | $46.00M | $36.16M |
| Gross Profit | $16.06M | $16.19M |
| Operating Income | $1.57M | $5.13M |
| Net Income | $1.79M | $4.24M |
| EPS (Diluted) | $0.02 | $0.07 |
Total Assets
$50.05M
Total Debt
$0.00
Shareholders' Equity
$17.63M
Cash & Equivalents
$1.29M
Operating Cash Flow
-$8.57M
Free Cash Flow
$0.00
Solesence, Inc. Common Stock Company Information
- President, CEO, CFO, Secretary & Director
- Jess A. Jankowski
- Headquarters
- 1319 Marquette Drive, Romeoville, IL, United States, 60446
- Website
- solesence.com
- Phone
- 630 771 6708
- IPO / Founded
- 2012-03-20
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products